Creatine Supplementation and Bone Mass
Primary Purpose
Osteopenia, Osteoporosis
Status
Completed
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
creatine supplementation
exercise training
placebo (dextrose)
Sponsored by
About this trial
This is an interventional treatment trial for Osteopenia focused on measuring creatine supplementation, resistance training, osteopenia, osteoporosis, bone mineral density
Eligibility Criteria
Inclusion Criteria:
- osteopenia and osteoporosis
- women older than 60 years old
Exclusion Criteria:
- cardiovascular diseases or muscular disturbances precluding exercise training
- drugs affecting bone metabolism
Sites / Locations
- School of Medicine - Division of Rheumatology
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Placebo Comparator
Experimental
Experimental
Placebo Comparator
Arm Label
control and exercise
creatine
exercise and creatine
placebo
Arm Description
this is trained and receives placebo
this is non-exercise trained and receives creatine supplementation
this is exercised trained and receives creatine supplementation
this only receives placebo (dextrose)
Outcomes
Primary Outcome Measures
bone mineral density
Secondary Outcome Measures
cognition
physical capacity
including muscle strength, balance and muscle function
Full Information
NCT ID
NCT01163370
First Posted
July 14, 2010
Last Updated
November 9, 2011
Sponsor
University of Sao Paulo
1. Study Identification
Unique Protocol Identification Number
NCT01163370
Brief Title
Creatine Supplementation and Bone Mass
Study Type
Interventional
2. Study Status
Record Verification Date
November 2011
Overall Recruitment Status
Completed
Study Start Date
July 2010 (undefined)
Primary Completion Date
August 2011 (Actual)
Study Completion Date
August 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Sao Paulo
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Resistance training as well as creatine supplementation may increase bone mass. Therefore, the investigators speculate that resistance training combined with creatine supplementation would promote additive benefits on bone mass in elderly women with osteopenia and osteoporosis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteopenia, Osteoporosis
Keywords
creatine supplementation, resistance training, osteopenia, osteoporosis, bone mineral density
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
60 (Actual)
8. Arms, Groups, and Interventions
Arm Title
control and exercise
Arm Type
Placebo Comparator
Arm Description
this is trained and receives placebo
Arm Title
creatine
Arm Type
Experimental
Arm Description
this is non-exercise trained and receives creatine supplementation
Arm Title
exercise and creatine
Arm Type
Experimental
Arm Description
this is exercised trained and receives creatine supplementation
Arm Title
placebo
Arm Type
Placebo Comparator
Arm Description
this only receives placebo (dextrose)
Intervention Type
Dietary Supplement
Intervention Name(s)
creatine supplementation
Intervention Description
20g/d for 7 days followed by 5g/d for 23 weeks
Intervention Type
Other
Intervention Name(s)
exercise training
Intervention Description
resistance training twice a week for 24 weeks
Intervention Type
Other
Intervention Name(s)
placebo (dextrose)
Intervention Description
20g/d for 7 days followed by 5g/d for 23 weeks
Primary Outcome Measure Information:
Title
bone mineral density
Time Frame
six months
Secondary Outcome Measure Information:
Title
cognition
Time Frame
six months
Title
physical capacity
Description
including muscle strength, balance and muscle function
Time Frame
six months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
osteopenia and osteoporosis
women older than 60 years old
Exclusion Criteria:
cardiovascular diseases or muscular disturbances precluding exercise training
drugs affecting bone metabolism
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rosa MR Pereira, PhD
Organizational Affiliation
University of Sao Paulo
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Bruno Gualano, PhD
Organizational Affiliation
University of Sao Paulo
Official's Role
Principal Investigator
Facility Information:
Facility Name
School of Medicine - Division of Rheumatology
City
Sao Paulo
ZIP/Postal Code
01246-903
Country
Brazil
12. IPD Sharing Statement
Learn more about this trial
Creatine Supplementation and Bone Mass
We'll reach out to this number within 24 hrs